Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 10

1.

Progestogens in menopausal hormone therapy.

Bińkowska M, Woroń J.

Prz Menopauzalny. 2015 Jun;14(2):134-43. doi: 10.5114/pm.2015.52154. Epub 2015 Jun 22. Review.

2.

Estrogen withdrawal, increased breast cancer risk and the KRAS-variant.

McVeigh TP, Jung SY, Kerin MJ, Salzman DW, Nallur S, Nemec AA, Dookwah M, Sadofsky J, Paranjape T, Kelly O, Chan E, Miller N, Sweeney KJ, Zelterman D, Sweasy J, Pilarski R, Telesca D, Slack FJ, Weidhaas JB.

Cell Cycle. 2015;14(13):2091-9. doi: 10.1080/15384101.2015.1041694. Epub 2015 May 11.

3.

Lobular breast cancer: incidence and genetic and non-genetic risk factors.

Dossus L, Benusiglio PR.

Breast Cancer Res. 2015 Mar 13;17:37. doi: 10.1186/s13058-015-0546-7. Review.

4.

Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55-74 years of age.

Li CI, Daling JR, Haugen KL, Tang MT, Porter PL, Malone KE.

Breast Cancer Res Treat. 2014 Jun;145(2):481-9. doi: 10.1007/s10549-014-2960-4. Epub 2014 Apr 20.

5.

Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.

Stanczyk FZ, Hapgood JP, Winer S, Mishell DR Jr.

Endocr Rev. 2013 Apr;34(2):171-208. doi: 10.1210/er.2012-1008. Epub 2012 Dec 13. Review.

7.

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.

LaCroix AZ, Chlebowski RT, Manson JE, Aragaki AK, Johnson KC, Martin L, Margolis KL, Stefanick ML, Brzyski R, Curb JD, Howard BV, Lewis CE, Wactawski-Wende J; WHI Investigators.

JAMA. 2011 Apr 6;305(13):1305-14. doi: 10.1001/jama.2011.382.

8.

Risk factors for ductal and lobular breast cancer: results from the nurses' health study.

Kotsopoulos J, Chen WY, Gates MA, Tworoger SS, Hankinson SE, Rosner BA.

Breast Cancer Res. 2010;12(6):R106. doi: 10.1186/bcr2790. Epub 2010 Dec 8.

9.

Low salivary testosterone levels in patients with breast cancer.

Dimitrakakis C, Zava D, Marinopoulos S, Tsigginou A, Antsaklis A, Glaser R.

BMC Cancer. 2010 Oct 11;10:547. doi: 10.1186/1471-2407-10-547.

10.

Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.

Phipps AI, Li CI, Kerlikowske K, Barlow WE, Buist DS.

Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1643-54. doi: 10.1158/1055-9965.EPI-10-0188. Epub 2010 May 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk